Presentation of SIVgag to monkey T cells using dendritic cells transfected with a recombinant adenovirus

European Journal of Immunology

Volumn 30, Issue 11, 2000, Pages 3281-3290

  Zhong, Lei ^a   Granelli Piperno, Angela ^a   Pope, Melissa ^a   Ignatius, Ralf ^a   Lewis, Mark G ^b   Frankel, Sarah Schlesinger ^b,c   Steinman, Ralph M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Dendritic cell; Recombinant adenovirus; Simian immunodeficiency virus; T cell immunity

Indexed keywords

GAMMA INTERFERON; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; GENE; GENETIC TRANSFECTION; MONKEY; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; ANTIGEN PRESENTATION; DENDRITIC CELLS; GENES, GAG; GENETIC VECTORS; HAPLORHINI; RECOMBINATION, GENETIC; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES; TRANSFECTION;

EID: 0033737314     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200011)30:11<3281::AID-IMMU3281>3.0.CO;2-4     Document Type: Article

References (37)

1. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
2. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
3. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
4. High levels of anti-human immunodeficiency virus type1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1 infected long-term non-progressors
5. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
6. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus env and Nef
7. + T cell depletion in simian immunodeficiency virus-infected macaques
8. + lymphocytes
9. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys
10. + T cell responses associated with control of viremia
11. Non-human primate models for AIDS vaccines
12. HIV vaccines-where are we going?
13. Immune responses elicited by recombinant vaccinia-human immunodeficiency virus (HIV) envelope and HIV protein: Analysis of the durability of responses and effect of repeated boosting
14. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination
15. Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization
16. Dendritic ceils and the control of immunity
17. Antigen presentation and related immunological aspects of HIV-1 vaccines
18. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
19. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo
20. Dendritic cells efficiently induce protective antiviral immunity
21. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model tumor antigen induce protective and therapeutic antitumor immunity
22. Dendritic cells retrovirally transduced with a model tumor antigen gene are therapeutically effective against established pulmonary metastases
23. Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus
24. + T cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene
25. Induction of anti-tumor immunity with dendritic cells transduced with adeno virus vector-encoding endogenous tumor-associated antigens
26. Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
27. Immunization with human papillomavirus type 16 (HPV 16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV-16-induced tumor cells
28. Rapid generation of broad T cell immunity in humans after single injection of mature dendritic cells
29. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells
30. + T cells in chronically infected HIV-1-positive individuals
31. Progress in the development of an HIV-1 vaccine
32. Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virus
33. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
34. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression
35. Murine dendritic cells transduced with an adenoviral vector expressing a defined tumor antigen can overcome anti-adenovirus neutralizing immunity and induce effective tumor regression
36. Generation of monocyte-derived cells from the precursors in rhesus macaque blood
37. Enumeration of lymphokine-secreting cells as a quantitative measure for cellular immune responses in rhesus macaques